Medical Condition News

RSS

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.

31 May 2024

Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...

An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the Basque Country (UPV/EHU) and researchers from the CIBER of Mental Health (CIBERSAM), and published in Nature Communications, may facilitate the creation of new personalized treatments for people diagnosed with schizophrenia.

30 May 2024

Wake Forest researchers to study bone health post-bariatric surgery with $1.5 million NIH grant

Researchers at Wake Forest University of School of Medicine have received a five-year, $1.5 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, to study bone microarchitecture in patients following bariatric surgery.

30 May 2024

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits.

30 May 2024

Thailand grapples with colorectal cancer epidemic

According to research led by Prof. Varut Lohsiriwat, Professor of Surgery, Division of General Surgery (Section of Colorectal Surgery) of Siriraj Hospital, at Mahidol University, CRC is the third most common cancer in Thailand, accounting for 11% of the cancer burden. It is the only malignancy with an increased incidence in both genders in the country.

30 May 2024

UQ receives $5 million from Medical Research Future Fund to improve treatment for post-stroke aphasia

The Queensland Aphasia Research Centre at The University of Queensland has been awarded almost $5 million from the Medical Research Future Fund to improve treatment for the growing number of Australians living with post-stroke aphasia.

30 May 2024

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Natural killer (NK) cells play a crucial role in the first line of host defense by eliminating bacteria, viruses, and mutated cells that might become cancer cells.

30 May 2024

Both too much and too little of a protein can lead to severe intellectual deficiencies

New research from the University of Lausanne reveals that both the excess and the deficiency of a single protein can lead to severe intellectual deficiencies.

30 May 2024

Dana-Farber study exposes hidden disparities in cancer care experiences

Four teams of Dana-Farber Cancer Institute investigators have found that people experience discrimination and bias in different ways and in more realms of cancer care than previously understood.

30 May 2024

Coupling bacteria-laden hydrogel and electronics for adaptive treatment of skin inflammation

Coupling skin bacteria-laden hydrogel and electronics, researchers have introduced the ABLE platform, a bioelectronics system that can deliver management and adaptive treatment of skin inflammation.

30 May 2024

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Many adults with diabetes and the associated complication of peripheral neuropathy, which can be painful as well as harmful, are often prescribed drugs at doses and for durations that could impose an increased risk of cognitive impairment.

30 May 2024

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

Osteoporosis, a condition characterized by porous and fragile bones, poses a significant threat to skeletal health.

30 May 2024

How tight binding between immune cells dictates T cell cancer-fighting ability

Immunotherapy, treatments that reinvigorate immune cells' anti-cancer activity or reprogram T cells to target cancer, has shown promise in treating leukemias but has not yet been realized in solid tumors.

30 May 2024

New surgical platform informs critical decision-making about tumor treatment within minutes

Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate.

30 May 2024

New AI tool analyzes medical history to match patients with best antidepressant

Researchers in George Mason University's College of Public Health have leveraged the power of artificial intelligence (AI) analytical models to match a patient's medical history to the most effective antidepressant, allowing patients to find symptom relief sooner.

30 May 2024

Older adults with a criminal background found to have higher risk of developing dementia

Using national registry data, Carmen Solares Canal identified individuals over fifty and collected data on their criminal convictions and health.

30 May 2024

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Aging-related physiological decline and the accumulation of senescent or aging cells in bodily tissues can trigger a number of diseases.

30 May 2024

Saudi Arabia lags in CRC screening despite high awareness of early detection benefits

According to the statistics of the Saudi National Cancer Registry issued by the Saudi Health Council for 2020, colorectal cancer (CRC) is ranked second among types of cancer, and first in men and third in women accounting for 12.3% with 1729 cases among all registered cancer cases.

30 May 2024

Mast cells and PGE2: Key players in controlling asthma inflammation

Previous research indicates that mast cells, a type of immune cell found in the tissues throughout the body, cause inflammation during an asthma attack, inducing symptoms such as trouble breathing and narrowing of the airways.

30 May 2024

Existing drug alleviates symptoms of a rare genetic syndrome

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

30 May 2024

Medical Condition News

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...

Wake Forest researchers to study bone health post-bariatric surgery with $1.5 million NIH grant

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Thailand grapples with colorectal cancer epidemic

UQ receives $5 million from Medical Research Future Fund to improve treatment for post-stroke aphasia

Research reveals how Regnase-1 deficiency enhances NK cell tumor killing

Both too much and too little of a protein can lead to severe intellectual deficiencies

Dana-Farber study exposes hidden disparities in cancer care experiences

Coupling bacteria-laden hydrogel and electronics for adaptive treatment of skin inflammation

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

How tight binding between immune cells dictates T cell cancer-fighting ability

New surgical platform informs critical decision-making about tumor treatment within minutes

New AI tool analyzes medical history to match patients with best antidepressant

Older adults with a criminal background found to have higher risk of developing dementia

Canagliflozin: A breakthrough in senolytic treatment for aging-related diseases

Saudi Arabia lags in CRC screening despite high awareness of early detection benefits

Mast cells and PGE2: Key players in controlling asthma inflammation

Existing drug alleviates symptoms of a rare genetic syndrome

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News